• SPX
  • $5,973.10
  • 0.74 %
  • $44.06
  • DJI
  • $43,729.34
  • -0 %
  • -$0.59
  • N225
  • $39,473.59
  • 0.23 %
  • $92.40
  • FTSE
  • $8,140.74
  • -0.32 %
  • -$25.94
  • IXIC
  • $19,269.46
  • 1.51 %
  • $285.99
Bausch Health Companies Inc. (BHC) Stock Price, News & Analysis

Bausch Health Companies Inc. (BHC) Stock Price, News & Analysis

Currency in USD Disclaimer

$9.43

-$0.07

(-0.74%)

Day's range
$9.19
Day's range
$9.5
50-day range
$5.84
Day's range
$9.85
  • Country: CA
  • ISIN: CA0717341071
52 wk range
$3.96
Day's range
$11.46


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -0.39
  • Piotroski Score 7.00
  • Grade Sector Perform
  • Symbol (BHC)
  • Company Bausch Health Companies Inc.
  • Price $9.43
  • Changes Percentage (-0.74%)
  • Change -$0.07
  • Day Low $9.19
  • Day High $9.50
  • Year High $11.46

Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb segment offers products with a focus on the vision care, surgical, and consumer, surgical, and ophthalmic pharmaceuticals products. The Salix segment provides gastroenterology products in the United States. The International Rx segment offers Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Ortho Dermatologics segment provides dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment offers pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.

  • Last Earnings 11/04/2010
  • Ex-Dividend for 5/16 Dividend 11/10/2010
  • Dividend Payable 12/22/2010
  • Today N/A
  • Next Earnings (Estimated) 02/19/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $9.00
  • High Stock Price Target $16.00
  • Low Stock Price Target $7.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$1.24
  • Trailing P/E Ratio -5.06
  • Forward P/E Ratio -5.06
  • P/E Growth -5.06
  • Net Income $-592,000,000

Income Statement

Quarterly

Annual

Latest News of BHC

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.